Registro:

Referencias:

• Matos, E.L., Loria, D.I., Zengarini, N., (2003) Atlas of cancer mortality in Argentina 1997-2001 (Spanish), , Fundación Bunge y Born, Buenos Aires (Argentina)
• Mueller, M.M., Fusening, N.E., Friends or foes. Bipolar effects of the tumour stroma in cancer (2004) Nature, 4, pp. 839-849
• Ribatti, D., Ennas, M.G., Vacca, A., Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma (2003) Eur J Clin Invest, 33, pp. 420-425
• Mauro, L.V., Bellido, M., Morandi, A., Association between mast cells of different phenotypes and angiogenesis in colorectal cancer (2008) Mol Med Rep, 1, p. 8
• Kankkunen, J.P., Harvima, I.T., Naukkarinen, A., Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions (1997) Int J Cancer, 72, pp. 385-388
• Imada, A., Shijubo, N., Kojima, H., Abe, S., Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma (2000) Eur Respir J, 15, pp. 1087-1093
• Takanami, I., Takeuchi, K., Naruke, M., Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma (2000) Cancer, 88, pp. 2686-2692
• Hallgren, J., Pejler, G., Biology of mast cell tryptase. An inflammatory mediator (2006) FEBS J, 273, pp. 1871-1895
• Blair, R.J., Meng, H., Marchese, M.J., Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor (1997) J Clin Invest, 99, pp. 2691-2700
• He, S., Peng, Q., Walls, A.F., Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine (1997) J Immunol, 159, pp. 6216-6225
• Kaminska, R., Helisalmi, P., Harvima, R.J., Naukkarinen, A., Horsmanheimo, M., Harvima, I.T., Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase (1999) J Invest Dermatol, 113, pp. 567-573
• Yoshii, M., Jikuhara, A., Mori, S., Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners (2005) J Pharmacol Sci, 98, pp. 450-458
• Muramatsu, M., Katada, J., Hattori, M., Hayashi, I., Majima, M., Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas (2000) Eur J Pharm, 402, pp. 181-191
• Fang, K.C., Raymond, W.W., Blount, J.L., Caughey, G.H., Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain (1997) J Biol Chem, 272, pp. 25628-25635
• Theoharides, T.C., Conti, P., Mast cells: the Jekyll and Hyde of tumor growth (2004) Trends Immunol, 25, pp. 235-241
• Norrby, K., Mast cells and angiogenesis (2002) APMIS, 110, pp. 355-371
• Ibaraki, T., Muramatsu, M., Takai, S., The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer (2005) Eur J Cardiothorac Surg, 28, pp. 617-621
• Tomita, M., Matsuzaki, Y., Onitsuka, T., Effect of mast cells on tumor angiogenesis in lung cancer (2000) Ann Thorac Surg, 69, pp. 1686-1690
• Welsh, T.J., Green, R.H., Richardson, D., Waller, D.A., O'Byrne, K.J., Bradding, P., Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer (2005) J Clin Oncol, 23, pp. 8959-8967
• Tomita, M., Matsuzaki, Y., Onitsuka, T., Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma (1999) Lung Cancer, 26, pp. 103-108
• Irani, A.M., Schwartz, L.B., Mast cell heterogeneity (1989) Clin Exp Allergy, 19, pp. 143-155
• Cabanillas-Saez, A., Schalper, J.A., Nicovani, S.M., Rudolph, M.I., Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix (2002) Int J Gynecol Cancer, 12, pp. 92-98
• Nagata, M., Shijubo, N., Walls, A.F., Ichimiya, S., Abe, S., Sato, N., Chymase-positive mast cells in small sized adenocarcinoma of the lung (2003) Virchows Arch, 443, pp. 565-573
• Rajput, A.B., Turbin, D.A., Cheang, M.C., Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases (2008) Breast Cancer Res Treat, 107, pp. 249-257
• Nielsen, H.J., Hansen, U., Christensen, I.J., Reimert, C.M., Brunner, N., Moesgaard, F., Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue (1999) J Pathol, 189, pp. 487-495
• Tataroglu, C., Kargi, A., Ozkal, S., Esrefoglu, N., Akkoclu, A., Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC) (2004) Lung Cancer, 43, pp. 47-54
• Dundar, E., Oner, U., Peker, B.C., Metintas, M., Isiksoy, S., Ak, G., The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma (2008) J Int Med Res, 36, pp. 88-95
• Nienartowicz, A., Sobaniec-Lotowska, M.E., Jarocka-Cyrta, E., Lemancewicz, D., Mast cells in neoangiogenesis (2006) Med Sci Monit, 12, pp. RA53-RA56
• Folkman, J., Shing, Y., Control of angiogenesis by heparin and other sulfated polysaccharides (1992) Adv Exp Med Biol, 313, pp. 355-364
• Powers, C.J., McLeskey, S.W., Wellstein, A., Fibroblast growth factors, their receptors and signaling (2000) Endocr Relat Cancer, 7, pp. 165-197
• Stack, M.S., Johnson, D.A., Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase) (1994) J Biol Chem, 269, pp. 9416-9419
• Coussens, L.M., Raymond, W.W., Bergers, G., Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis (1999) Genes Dev, pp. 1382-1397
• de Visser, K.E., Eichten, A., Coussens, L.M., Paradoxical roles of the immune system during cancer development (2006) Nat Rev Cancer, 6, pp. 24-37

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------